| Literature DB >> 31516454 |
Sharifa Ezat Wan Puteh1, Roslina Abdul Manap2, Tidi Maharani Hassan2, Izzah Syazwani Ahmad1, Idayu Badilla Idris1, Fariza Md Sham3, Andrea Ban Yu Lin2, Chun Ian Soo2, Rashidi Mohamed Pakri Mohamed4,5, Ahmad Irdha Mokhtar3, Hazli Zakaria6, Jing Lee7, Amer Siddiq Amer Nordin5, Suthahar Ariaratnam8, Mohd Zaliman Mohd Yusoff9.
Abstract
INTRODUCTION: E-cigarette use is an emerging phenomenon with increasing recognition and acceptance globally. This study aims to create a profile of e-cigarette users among university students in Malaysia.Entities:
Keywords: Malaysia; electronic cigarettes; smoking; students; university
Year: 2018 PMID: 31516454 PMCID: PMC6659562 DOI: 10.18332/tid/99539
Source DB: PubMed Journal: Tob Induc Dis ISSN: 1617-9625 Impact factor: 2.600
Distribution of sociodemographic characteristics of respondents (n=1302 )
| 18–20 | 376 | 28.9 |
| 21–25 | 880 | 67.6 |
| 26–30 | 38 | 2.9 |
| >30 | 8 | 0.6 |
| Male | 1234 | 94.8 |
| Female | 68 | 5.2 |
| Malay | 979 | 75.2 |
| Chinese | 98 | 7.5 |
| Indian | 162 | 12.4 |
| Others (e.g. Kedayan, Bajau, Bangladesh, Indonesia) | 63 | 4.8 |
| Malaysian | 1275 | 97.9 |
| Others (e.g. Bangladesh, Indonesia, Mexico) | 26 | 2.1 |
| Single/unmarried | 1276 | 98.0 |
| Married | 26 | 2.0 |
| Diploma | 373 | 28.6 |
| Degree | 849 | 65.2 |
| Masters | 72 | 5.5 |
| PhD/DrPH | 8 | 0.6 |
| ≤2000 | 273 | 24.5 |
| 2001–4000 | 307 | 27.5 |
| 4001–6000 | 244 | 21.9 |
| 6001–8000 | 99 | 8.9 |
| 8001–10000 | 106 | 9.5 |
| ≥10001 | 87 | 7.8 |
| None (healthy) | 1199 | 92.1 |
| Asthma | 64 | 4.9 |
| High cholesterol | 13 | 1.0 |
| High blood pressure | 7 | 0.5 |
| Diabetes mellitus | 2 | 0.2 |
| Kidney problem | 3 | 0.2 |
| Heart disease | 4 | 0.3 |
| Others (e.g Allergic, Migraine, Gastric, Cancer) | 21 | 1.6 |
Figure 1Cigarette/e-cigarette users among students (n=1302 )
Respondents smoking/e-cigarette-use profile
| <10 | 39 | 3.8 |
| 10–15 | 380 | 36.7 |
| 16–20 | 569 | 54.9 |
| 21–25 | 48 | 4.6 |
| Yes | 679 | 53.5 |
| No | 605 | 46.5 |
| Did not answer | 36 | 3.5 |
| ≤5 | 584 | 56.4 |
| 6–10 | 252 | 24.3 |
| 11–15 | 76 | 7.3 |
| 16–20 | 70 | 6.8 |
| ≥ 21 | 18 | 1.8 |
| Standard | 791 | 76.4 |
| Light | 279 | 26.9 |
| Menthol | 218 | 21.0 |
| Tobacco (Indonesia) | 151 | 14.6 |
| Cigar/Curut | 55 | 5.3 |
| Others (e.g. Harvest, John, U2, Mevius) | 37 | 3.6 |
| Family | 100 | 7.7 |
| Product seller | 160 | 12.3 |
| Advertisement | 189 | 14.5 |
| University student | 749 | 57.5 |
| Internet | 476 | 36.6 |
| Magazines | 80 | 6.1 |
| Outside peer | 488 | 37.5 |
| Media | 349 | 28.8 |
| Unsure | 127 | 9.8 |
| Wholesale | 109 | 8.4 |
| Booth seller | 135 | 10.4 |
| Family member | 32 | 2.5 |
| Retailer | 493 | 37.9 |
| Online | 193 | 14.8 |
| Exchange among peers | 126 | 9.7 |
| University student | 229 | 17.6 |
| Outside peers | 144 | 11.1 |
| Unsure | 187 | 14.4 |
| 1 | 387 | 76.5 |
| 2 | 81 | 16.0 |
| 3 | 21 | 4.2 |
| ≥ 4 | 17 | 3.6 |
| Local | 542 | 55.6 |
| Imported | 433 | 44.4 |
| Without nicotine (no flavours) | 178 | 18.3 |
| Without nicotine (with flavours) | 85 | 8.7 |
| ≤6 mg nicotine | 312 | 32.0 |
| ≤9 mg nicotine | 84 | 8.6 |
| ≤12 mg nicotine | 79 | 8.1 |
| ≥16 mg nicotine | 23 | 2.4 |
| Unsure | 212 | 21.7 |
| Unanswered | 2 | 0.2 |
e.g. mango, mint, redbull, grape, vanilla.
Adverse events occurrence based on types of cigarette/e-cigarette users
| None | 302 (33.0) | 175 (19.1) | 111 (12.1) | 244 (26.7) | 83 (9.1) | 193.488 | <0.001 |
| 1 Symptom | 103 (54.5) | 47 (24.9) | 39 (20.6) | 0 (0.0) | 0 (0.0) | ||
| 2 Symptoms | 57 (58.8) | 21 (21.6) | 19 (19.6) | 0 (0.0) | 0 (0.0) | ||
| ≥3 Symptoms | 63 (62.4) | 23 (22.8) | 15 (14.9) | 0 (0.0) | 0 (0.0) | ||
| Total | 525 (40.3) | 266 (20.4) | 184 (14.1) | 244 (18.7) | 83 (6.4) | ||
Chi-squared test. Values are expressed as frequency and per cent (n, %). p<0.05 compares dual users, e-cigarette user (never smoker), e-cigarette user (ex-smoker), smoker (never use e-cigarette) and ex-smoker (never use e-cigarette).
Figure 2Students opinion on the most effective alternative for smoking cessation (n=1036 )
Association between dual user and e-cigarette (e-cig) users with sociodemographics, adverse events occurrence, comorbidity disease and reason for e-cigarette use initiation among students (n=975 )
| Public | 277 (28.4) | 226 (23.2) | 0.63 | 0.43 | 1.11 | 0.86 | 1.42 |
| Private | 248 (25.4) | 224 (23.0) | |||||
| ≤ 21 | 320 (32.8) | 296 (30.4) | 2.42 | 0.12 | 0.81 | 0.62 | 1.05 |
| > 21 | 205 (21.0) | 154 (15.8) | |||||
| Male | 516 (52.9) | 412 (42.3) | 23.92 | <0.001 | 0.19 | 0.09 | 0.40 |
| Female | 9 (0.9) | 38 (3.9) | |||||
| Malay | 400 (41.0) | 350 (35.9) | 0.34 | 0.56 | 1.09 | 0.81 | 1.48 |
| Others | 125 (12.8) | 100 (10.3) | |||||
| Single | 516 (52.9) | 441 (45.2) | 0.11 | 0.74 | 0.85 | 0.34 | 2.17 |
| Married | 9 (0.9) | 9 (0.9) | |||||
| Degree | 351 (36.0) | 280 (28.7) | 2.28 | 0.13 | 0.82 | 0.63 | 1.06 |
| Others | 174 (17.8) | 170 (17.4) | |||||
| ≤ RM4000 | 228 (27.8) | 206 (25.1) | 0.01 | 0.93 | 0.99 | 0.75 | 1.30 |
| > RM4000 | 204 (24.9) | 182 (22.2) | |||||
| ≤ 2 symptoms | 462 (47.4) | 412 (42.3) | 3.30 | 0.07 | 0.68 | 0.44 | 1.03 |
| >2 symptoms | 63 (6.5) | 38 (3.9) | |||||
| None (healthy) | 484 (49.6) | 407 (41.7) | 0.94 | 0.33 | 1.25 | 0.80 | 1.95 |
| Having comorbidity | 41 (4.2) | 43 (4.4) | |||||
| Low | 156 (16.0) | 189 (19.4) | 16.00 | <0.001 | 0.58 | 0.45 | 0.76 |
| High | 369 (37.8) | 261 (26.8) | |||||
| Low | 236 (24.2) | 205 (21.0) | 0.04 | 0.85 | 0.98 | 0.76 | 1.26 |
| High | 289 (29.6) | 245 (25.1) | |||||
| Low | 162 (16.6) | 184 (18.9) | 10.65 | <0.001 | 0.64 | 0.50 | 0.84 |
| High | 363 (37.2) | 266 (27.3) | |||||
| Low | 195 (20.0) | 169 (17.3) | 0.02 | 0.89 | 0.98 | 0.76 | 1.27 |
| High | 330 (33.8) | 281 (28.8) | |||||
| Low | 190 (19.5) | 221 (22.7) | 16.59 | <0.001 | 0.59 | 0.45 | 0.76 |
| High | 335 (34.4) | 229 (23.5) | |||||
| Low | 186 (19.1) | 179 (18.4) | 1.96 | 0.16 | 0.83 | 0.64 | 1.08 |
| High | 339 (34.8) | 271 (27.8) | |||||
Data exclude non-e-cigarette user with analysis using chi-squared test. E-cigarette user refers to exclusive e-cigarette user. OR: odds ratio, CI: confidence interval.
p<0.05 indicates significant difference does exist.
Factors associated with e-cigarette users in univariate and multivariate analysis among students (n=975 )
| ≤ 21 (reference) | 0.12 | 0.81 | 0.62–1.05 | 0.17 | 0.82 | 0.62–1.09 |
| >21 | ||||||
| Female (reference) | <0.001* | 0.19 | 0.09–0.40 | <0.001* | 0.18 | 0.09–0.39 |
| Male | ||||||
| Others (reference) | 0.56 | 1.09 | 0.81–1.48 | 0.17 | 1.24 | 0.91–1.71 |
| Malay | ||||||
| Others (reference) | 0.13 | 0.82 | 0.63–1.06 | 0.44 | 0.89 | 0.67–1.19 |
| Degree | ||||||
| ≤ 2 symptoms (reference) | 0.07 | 0.68 | 0.44–1.03 | 0.05 | 0.65 | 0.42–1.01 |
| >2 symptoms | ||||||
| None (reference) | 0.33 | 1.25 | 0.80–1.9 | 0.29 | 1.29 | 0.81–2.05 |
| Having comorbidity | ||||||
| Low (reference) | <0.001* | 0.58 | 0.45–0.76 | 0.27 | 0.82 | 0.59–1.16 |
| High | ||||||
| Low (reference) | 0.001* | 0.64 | 0.50–0.84 | 0.34 | 0.85 | 0.61–1.19 |
| High | ||||||
| Low (reference) | <0.001* | 0.59 | 0.45–0.76 | 0.06 | 0.72 | 0.51–1.01 |
| High | ||||||
Data exclude non-e-cigarette user with analysis using logistic regression. E-cigarette user refers to exclusive e-cigarette user. AOR: adjusted odds ratio, CI: confidence interval. *p<0.05 indicates significant difference does exist.